Vasculogenic mimicry of acute leukemic bone marrow stromal cells (Q46064717)

19 December 2017

title

Vasculogenic mimicry of acute leukemic bone marrow stromal cells (English)

1 reference

19 December 2017

1 reference

1 reference

P Mirshahi

1

1 reference

19 December 2017

A Rafii

2

1 reference

19 December 2017

L Vincent

3

1 reference

19 December 2017

A Berthaut

4

1 reference

19 December 2017

R Varin

5

1 reference

19 December 2017

G Kalantar

6

1 reference

19 December 2017

C Marzac

7

1 reference

19 December 2017

O A Calandini

8

1 reference

19 December 2017

J-P Marie

9

1 reference

19 December 2017

C Soria

10

1 reference

19 December 2017

J Soria

11

1 reference

19 December 2017

M Mirshahi

12

1 reference

19 December 2017

publication date

2 April 2009

1 reference

19 December 2017

published in

Leukemia

1 reference

19 December 2017

volume

23

1 reference

19 December 2017

issue

6

1 reference

19 December 2017

page(s)

1039-1048

1 reference

19 December 2017

Tumor angiogenesis: a possible control point in tumor growth

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.10

Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.10

Vasculogenic mimicry and tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.10

Angiogenesis in hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.10

7 January 2021

Angiogenesis and angiogenic mediators in haematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.10

7 January 2021

Assessment of bone marrow angiogenesis in patients with acute myeloid leukemia by using contrast-enhanced MR imaging with clinically approved iron oxides: initial experience.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.10

7 January 2021

Angiogenesis and antiangiogenic therapy in hematologic malignancies.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.10

7 January 2021

Angiogenesis in hematologic malignancies and its clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.10

7 January 2021

Increased bone marrow vascularization in patients with acute myeloid leukaemia: a possible role for vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.10

7 January 2021

Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.10

7 January 2021

Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.10

7 January 2021

Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.10

7 January 2021

The growth of highly proliferative acute lymphoblastic leukemia may be independent of stroma and/or angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.10

7 January 2021

Angiogenic factors may have a different prognostic role in adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.10

7 January 2021

Chimaeric cultures of human marrow stroma and murine leukaemia cells: evidence for abnormalities in the haemopoietic microenvironment in myeloid malignancies and other infiltrating marrow disorders

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.10

7 January 2021

Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5).

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.10

7 January 2021

A technique for rapid isolation of bone marrow mononuclear cells using Ficoll-Metrizoate and the IBM 2991 blood cell processor

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.10

7 January 2021

Malignant hematopoietic cells induce an increased expression of VEGFR-1 and VEGFR-3 on bone marrow endothelial cells via AKT and mTOR signalling pathways

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.10

7 January 2021

Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase/Akt pathway

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.10

7 January 2021

SDF-1 activity on microvascular endothelial cells: consequences on angiogenesis in in vitro and in vivo models.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.10

7 January 2021

Stromal cell-derived factor-1/CXCR4 signaling modifies the capillary-like organization of human embryonic stem cell-derived endothelium in vitro

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.10

7 January 2021

Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.10

7 January 2021

Insulin-mediated stimulation of protein kinase Akt: A potent survival signaling cascade for endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.10

7 January 2021

Expression of Tie-2 and Other Receptors for Endothelial Growth Factors in Acute Myeloid Leukemias Is Associated with Monocytic Features of Leukemic Blasts

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.10

7 January 2021

Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.10

7 January 2021

Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.10

7 January 2021

Bevacizumab reduces VEGF expression in patients with relapsed and refractory acute myeloid leukemia without clinical antileukemic activity

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.10

7 January 2021

Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.10

7 January 2021

Identifiers

DOI

10.1038/LEU.2009.10

1 reference

19 December 2017

Dimensions Publication ID

1024254889

0 references

Fatcat ID

release_eaenirajm5an5omsrxmryuubva

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/eaenirajm5an5omsrxmryuubva

24 November 2022

mapped directly with Wikidata item

1 reference

19 December 2017